ArticleMedical & biological engineering & computing2022
MLRD-Net: 3D multiscale local cross-channel residual denoising network for MRI-based brain tumor segmentation.
Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sixty years in service to international biomedical engineering community.Medical & biological engineering & computing · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The precise segmentation of multimodal MRI images is the primary stage of tumor diagnosis and treatment. Current segmentation strategies often underutilize multiscale features, which can easily lead to loss of contextual information, reduction of low-level features and noise interference. To overcome these issues, a 3D multiscale local cross-channel residual denoising network (MLRD-Net) for an MRI-based brain tumor segmentation algorithm is proposed in this paper. Specifically, we employ encoder-decoder structure to connect local and global features, and enhance the receptive field of the network. Random slice operation has been conducted to enhance robustness. Then, residual blocks with pre-activation operation are developed in down-sampling stage, which effectively improves signal propagation along the network and alleviates network overfitting. Finally, the local cross-channel denoising mechanism is established to eliminate unimportant features without dimensionality reduction. Our proposal was evaluated in Brain Tumor Segmentation 2020 dataset (BraTS 2020), obtaining significantly improved results with mean Dice Similarity Coefficient metric of 0.91, 0.79, and 0.73 for the complete, tumor core, and enhancing tumor regions respectively. Besides, we conduct further practice on BraTS 2019, with the mean Dice Similarity Coefficient metric of 0.89, 0.80, and 0.75. Massive experiments demonstrate that our method is powerful and reliable. It increases little model complexity while achieving very competitive performance.
Indexed as
Identifiers
36190611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.